Related Experiment Video

Updated: Apr 28, 2026

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
10:10

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

8.9K

RNA interference technology for anti-VEGF treatment

Shun Chen1, Jia Feng, Liuqing Ma

  • 1Xinhua Hospital Affiliated to Shanghai JiaoTong University, School of Medicine, Department of Neurology , 1665 Kongjiang Road, Shanghai 200092 , People's Republic of China +86 21 65790000 ; +86 21 65790000 ; zhenguoliu2004@aliyun.com.

Expert Opinion on Drug Delivery
|June 6, 2014
PubMed
Abstract

Insights

RNA interference (RNAi) offers a promising, effective, and safe approach to inhibit vascular endothelial growth factor (VEGF) for treating diseases like cancer and retinopathy, potentially overcoming limitations of current therapies.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Medical Science

Background:

  • Vascular Endothelial Growth Factor (VEGF) overexpression is linked to pathological conditions including tumors and retinopathy.
  • Current treatments like small molecule inhibitors and monoclonal antibodies have limitations including complex development, short half-life, and systemic side effects.
  • There is a significant clinical need for more effective and safer therapeutic technologies.

Purpose of the Study:

  • To review current advancements in RNA interference (RNAi) technology for anti-VEGF therapeutic strategies.
  • To explore potential future clinical applications of RNAi in treating VEGF-associated diseases.

Main Methods:

  • Review of current scientific literature and clinical trial data on RNAi technology.
  • Analysis of the efficacy and safety profiles of RNAi-based anti-VEGF agents.
  • Consideration of future clinical strategies for RNAi application.

Main Results:

  • RNAi technology demonstrates significant potential for inhibiting gene expression at the post-transcriptional level.
  • RNAi-based approaches are being investigated in various clinical trials for anti-VEGF therapies.
  • The technology offers advantages in terms of ease of design and high efficacy compared to traditional methods.

Conclusions:

  • RNAi technology presents a promising future for anti-VEGF treatment, with many investigations yielding encouraging results.
  • Further development and clinical trials of RNAi-based anti-VEGF candidates are anticipated.
  • RNAi may represent a novel and effective therapeutic strategy for VEGF-driven diseases.
Keywords:
RNA interferingVEGFage-related macular degenerationangiogenesisanti-VEGFgene deliverysmall interfering RNAtumor

More Related Videos

Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy09:46

Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy

Published on: February 26, 2021

2.6K
A Rabbit Model of Durable Transgene Expression in Jugular Vein to Common Carotid Artery Interposition Grafts13:58

A Rabbit Model of Durable Transgene Expression in Jugular Vein to Common Carotid Artery Interposition Grafts

Published on: September 10, 2018

10.1K

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
24.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K